A. M. C.-L. Ho

Learn More
Acamprosate has been widely used since the Food and Drug Administration approved the medication for treatment of alcohol use disorders (AUDs) in 2004. Although the detailed molecular mechanism of acamprosate remains unclear, it has been largely known that acamprosate inhibits glutamate action in the brain. However, AUD is a complex and heterogeneous(More)
construct of impulsivity has been approached from three different perspectives: cognitive, behavioral and characterological. Starting with the latter, Eysenck conceived impulsivity as related to risk taking, lack of planning, and making up one's mind quickly. Several theories of substance-use have incorporated this eysenckian definition of the term using(More)
  • 1